Tumor microenvironment (TME) of HRAS mutated non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Trabolsi, A. [1 ]
Rodriguez, E. [2 ]
Kareff, S. [1 ]
Gallegos, J. A. Ocejo [3 ]
Yin, J. [4 ]
Walker, P. [5 ]
Mamdani, H. [6 ]
Nieva, J. J. [7 ]
Borghaei, H. [8 ]
Nabhan, C. [4 ]
Nagasaka, M. [9 ]
Puri, S. [10 ]
Liu, S. V. [11 ]
Halmos, B. [12 ]
Lopes, G. [13 ]
机构：
[1] Univ Miami, Dept Hematol Oncol, Sylvester Comprehens Canc Ctr, Miami, FL USA
[2] Univ Miami, Dept Internal Med, Sylvester Comprehens Canc Ctr, Miami, FL USA
[3] Jackson Mem Hosp, Dept Internal Med, UM Miller Sch Med, Internal Med Prog, Miami, FL USA
[4] Arizona Off, Caris Life Sci, CMI, Phoenix, AZ USA
[5] Caris Life Sci Headquarters, CMI, Irving, TX USA
[6] Karmanos Canc Inst, Dept Oncol, Detroit, MI USA
[7] Univ Southern Calif, Dept Oncol, USC, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[8] Fox Chase Canc Ctr, Dept Hematol Oncol, Main Campus, Philadelphia, PA USA
[9] Univ Calif Irvine, Med, UCI Hlth, Orange, CA USA
[10] Huntsman Canc Inst, Med Hematol & Oncol, Utah, UT USA
[11] Georgetown Univ, Dept Oncol, Lombardi Canc Ctr, Washington, DC USA
[12] Montefiore Med Ctr, Oncol, New York, NY USA
[13] Univ Miami, Dept Oncol, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1192
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1066P
引用
收藏
页码：S1041 / S1041
页数：1
相关论文
共 50 条
  • [21] Metformin has Divergent Effects on the Tumor Immune Microenvironment of Non-Small Cell Lung Cancer (NSCLC) Depending on Obesity
    Barbi, J.
    Zollo, R.
    Sass, S.
    Patnaik, S.
    Yendamuri, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S868 - S869
  • [22] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [23] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [24] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [25] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [26] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [27] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [28] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
12345